Introduction

“A Healthy World without Discrimination based on Age, Gender, Region, Race, Wealth, or Disability.”

Since its establishment in 2014 with the belief that the future of healthcare should shift from treatment-centered to a focus on early diagnosis and prevention, SMALLMACHINES has been developing on-site in vitro diagnostic medical devices capable of diagnosing various diseases, based on the convergence of IT, NT (Nanotechnology), and BT (Biotechnology) technologies.

Through the development of highly accurate and field-ready innovative medical devices, we aim to build a personalized health management platform that enables timely prevention and response. This will help reduce the time and costs associated with disease treatment and lead the innovation of 4P (Predictive, Preventive, Personalized, Participatory) future healthcare.

As an expert in the POCT (Point-of-Care Testing) field, SMALLMACHINES is committed to leading the global bio-healthcare market and will strive to realize universal healthcare, where everyone can access quality medical services equally.

We kindly ask for your continued interest and support in SMALLMACHINES' grand journey toward creating a healthy and happy world without discrimination based on age, gender, region, race, wealth, or disability. We sincerely thank everyone who always supports us.
Thank you.